GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
P/S ratio for GlycoMimetics (GLYC)
P/S ratio as of April 2024 (TTM): > 1000
According to GlycoMimetics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10531.2. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for GlycoMimetics from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 617.53% |
| 2022 | > 1000 | 3196.87% |
| 2021 | 64.2 | 254.23% |
| 2020 | 18.1 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | -100% |
| 2016 | > 1000 | 139981.89% |
| 2015 | 5.43 | -40.17% |
| 2014 | 9.07 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.79 | -99.96% | 🇺🇸 USA |
 Pfizer PFE | 2.46 | -99.98% | 🇺🇸 USA |
 Sanofi SNY | 2.44 | -99.98% | 🇫🇷 France |
 Palatin Technologies PTN | 4.13 | -99.96% | 🇺🇸 USA |
 bluebird bio
BLUE | 8.21 | -99.92% | 🇺🇸 USA |